Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT02394002
Other study ID # 2013071151
Secondary ID
Status Recruiting
Phase N/A
First received March 16, 2015
Last updated March 19, 2015
Start date March 2015
Est. completion date March 2017

Study information

Verified date March 2015
Source Heinrich-Heine University, Duesseldorf
Contact Andrea Szelényi, Prof.
Phone +49 211 8117646
Email andrea.szelenyi@uni-duesseldorf.de
Is FDA regulated No
Health authority Germany: Ethics Commission, Heinrich Heine University, Duesseldorf
Study type Interventional

Clinical Trial Summary

The relation between burst and suppression periods in transcranial and direct cortical recorded EEG with cortical amplitudes median nerve somatosensory evoked potentials is studied.

60 patients are included in this study: 15 patients undergoing brain tumor surgery, 15 spine surgery (University Hospital Düsseldorf) and 30 patients during general surgical procedures (Helios Klinikum Wuppertal).


Recruitment information / eligibility

Status Recruiting
Enrollment 60
Est. completion date March 2017
Est. primary completion date March 2016
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Location Helios Klinikum Wuppertal: neurological healthy patients, which undergo an elective surgery under general anaesthesia

- Location Department of Neurosurgery, University Hospital Düsseldorf: all patients with intracranial interventions and the possibility to place a stripe electrode without complications on cortex (it is decided by the surgeon while surgery because of the situs and tumorlocation)

Exclusion Criteria:

- periodical consumption of drugs and pharmaceuticals which influence cortical excitability

- intraoperative contraindication for required depth of anaesthesia

- neurological pre-existing illness

- advanced hepatic insufficiency

Study Design

Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Basic Science


Related Conditions & MeSH terms

  • Somatosensory Evoked Potentials, and Electroencephalography

Intervention

Drug:
Propofol


Locations

Country Name City State
Germany Neurosurgical Clinic Duesseldorf

Sponsors (3)

Lead Sponsor Collaborator
Andrea Szelenyi Department of Anaesthesiology, Heinrich Heine University, Department of Anesthesiology, Helios Klinikukm Wuppertal

Country where clinical trial is conducted

Germany, 

Outcome

Type Measure Description Time frame Safety issue
Primary SEP ampiltude in burst-suppression-EEG 2 hours No